03 January 2023 | News
Initial cases have now been performed in India
Teleflex Incorporated, based in the US, has announced the commercial launch of the UroLift System in India for treating benign prostatic hyperplasia (BPH), or enlarged prostate. BPH is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life.
The UroLift System is a minimally invasive approach to treating BPH that can be performed as a same-day outpatient procedure. The UroLift System provides rapid symptom relief for men with BPH and allows a quick recovery time for patients.
Arun Kaushik, Managing Director, South Asia, Teleflex said, “This technology offers clinical benefits in the minimally invasive treatment of BPH and offers physicians more options in how they treat their patients."
BPH cases with the UroLift system have been performed in Max Super Specialty Hospital (Saket), Medanta The Medicity (Gurugram), Manipal Hospital (HAL Road, Bengaluru,) and CURI Hospital (Chennai).
The UroLift System is a minimally invasive treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). It is indicated for the treatment of symptoms of an enlarged prostate up to 100 cc in men 50 years and above in India.
In India, a prostatic urethral lift like UroLift is an optional therapy and shall be offered as an alternative to patients presenting with moderate-to-severe LUTS who failed to respond to medical management and who are not tolerant or compliant to medical management.